FCA State
This archive displays posts tagged as relevant to state and local False Claims Acts. You may also be interested in the following pages:
Oklahoma City Hospital, Management Company, And Physician Group to Pay $72.3 Million To Settle Kickback and Stark Allegations
Posted 07/10/20
July 8, 2020
An orthopedic hospital, its management company, a physician’s group, and two physicians have agreed to pay $72.3 million to resolve whistleblower-brought allegations under the Anti-Kickback Statute, federal False Claims Act, and Oklahoma Medicaid False Claims Act of defrauding Medicare, Medicaid, and TRICARE. Between 2006 and 2018, the Oklahoma Center for Orthopaedic and Multi-Specialty Surgery (OCOM) and its part-owner and management company, USP OKC, Inc. and USP OKC Manager, Inc. (collectively USP), allegedly provided free or below-fair market rate services and compensation to Southwest Orthopaedic Specialists, PLLC (SOS), including SOS physicians Anthony Cruse, D.O., and R.J. Langerman, Jr., D.O., in exchange for patient referrals. USP also allegedly offered preferential investment opportunities to physicians in Texas. As part of the settlement, USP will pay $60.86 million to the United States, $5 million to the State of Oklahoma, and $206,000 to the State of Texas, while SOS and its physician defendants will pay $5.7 million to the United States and $495,619 to the State of Oklahoma. DOJJuly 1, 2020
Novartis Pharmaceuticals Corporation will pay a total of $678 million to resolve a case brought by a whistleblower, Oswald Bilotta, alleging that between 2002 and 2011 the pharmaceutical company violated the Anti-Kickback Statute and False Claims Act by providing doctors with cash payments and luxury travel and meals to induce them to prescribe Novartis cardiovascular and diabetes drugs reimbursed by federal healthcare programs. The total settlement consists of $591.4 million as federal FCA damages, $48.2 million as state FCA damages for Medicaid false claims submitted to 28 states and the District of Columbia, and $38.4 million as forfeiture under the Anti-Kickback Statute. The whistleblower award has not yet been determined. In addition to the monetary settlement, Novartis entered into a Corporate Integrity Agreement obligating the company to, among other things, significantly reduce its volume and spending on paid speaker programs. DOJ; USAO SDNY; CA AG; MI AG; NY AGJune 24, 2020
Augusta University Medical Center (AUMC) has agreed to pay $2.6 million to resolve fraud allegations by the United States, State of Georgia, and State of South Carolina under state and federal False Claims Acts. According to the government, AUMC knowingly submitted claims to Medicare and Medicaid for a medically unnecessary procedure that was billed as a covered procedure. USAO SDGAProtests Turn a Glaring Spotlight on the Big Business of Outfitting the Police
Posted 06/4/20
Constantine Cannon and GAP Collaborate to Form Covid-19 Legislative Team to Help Enact State False Claims Acts
Posted 05/29/20
The Need for...
Constantine Cannon’s Hackathon Challenge Generates Eleven Innovative Solutions to Protect COVID-19 Whistleblowers
Posted 05/29/20
